-

Guardian Pharmacy Services, Inc. to Participate in Upcoming Investor Conference

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation’s largest long-term care (LTC) pharmacy services companies, today announced that they will participate in the Raymond James & Associates’ 46th Annual Institutional Investors Conference, being held in Orlando, on Monday, March 3, 2025, including a presentation at 9:50am ET. The live audio webcast of the presentation will be available online at https://investors.guardianpharmacy.com. A replay of the presentation will also be available shortly after the Conference’s completion via the same link and will remain available until the Q1 2025 earnings release.

About Guardian Pharmacy Services

Guardian Pharmacy Services is a leading long-term care pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of long-term health care facilities (“LTCFs”) adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. As of September 30, 2024, our 50 pharmacies served approximately 180,000 residents in approximately 6,800 LTCFs across 37 states.

Contacts

GuardianPharmacyIR@icrhealthcare.com

Industry:

Guardian Pharmacy Services, Inc.

NYSE:GRDN
Release Versions
English

Contacts

GuardianPharmacyIR@icrhealthcare.com

More News From Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services Announces Filing of S-3 Shelf Registration Statement and Lock-up Agreements with Pre-IPO Holders of Class A Common Stock

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) (“Guardian”), one of the nation’s leading long-term care (LTC) pharmacy services companies, today announced that it has filed a shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission (SEC). The registration statement relates to (i) the possible issuance and sale of up to 1,020,000 shares of Class A common stock by Guardian and (ii) the potential resale of up to 4,980,000 outstanding shares...

Guardian Pharmacy Services Announces Pricing of Underwritten Public Offering of Class A Common Stock

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the pricing of the previously announced underwritten public offering (the “Offering”) of 7,500,000 shares of its Class A common stock, at a public offering price of $21.00 per share, of which 6,059,553 shares will be sold by certain selling stockholders and 1,440,447 shares will be issued and sold by Guardian as part of a non-dilutive “synthetic secondary” transaction, as described below. In add...

Guardian Pharmacy Services Announces Launch of Underwritten Public Offering of Class A Common Stock

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the launch of a proposed underwritten public offering (the “Offering”) of 7,500,000 shares of its Class A common stock, consisting of 6,059,553 shares being offered by certain selling stockholders and 1,440,447 newly issued shares being offered by Guardian as part of a non-dilutive “synthetic secondary” transaction, as described below. In addition, the selling stockholders intend to grant the un...
Back to Newsroom